Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Tokyo  >  Kyowa Hakko Kirin Co Ltd    4151   JP3256000005

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on KYOWA HAKKO KIRIN CO LTD
06/26 KYOWA HAKKO KIRIN : Cantargia licenses BioWa POTELLIGENT® Technology platform fo..
06/26 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
06/16 KYOWA HAKKO KIRIN : Launch of REGPARA Tablets 12.5mg in Japan
06/16 KYOWA HAKKO KIRIN : Launch of REGPARA Tablets 12.5mg in Japan
06/11 KYOWA HAKKO KIRIN : Patent Application Titled "Pharmaceutical Composition Compri..
06/03 Ultragenyx Releases Positive 16-Week Interim Data From Pediatric Phase 2 Stud..
05/06 KYOWA HAKKO KIRIN : Study Data from Kyowa Hakko Kirin Co. Ltd. Provide New Insig..
05/06 ArQule Reports First Quarter 2015 Financial Results
04/09 KYOWA HAKKO KIRIN : Completion of Construction for Amino Acid Manufacturing Plan..
04/01 KYOWA HAKKO KIRIN : Entries Now Publicly Available from the 'Commitment to Life'..
04/01 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/31 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/31 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/25 KYOWA HAKKO KIRIN : Patent Issued for Pharmaceutical Composition Comprising Anti..
03/25 KYOWA HAKKO KIRIN : New Immunoglobulins Data Have Been Reported by Researchers a..
03/20 KYOWA HAKKO KIRIN : Notice regarding allotment of stock acquisition rights(stock..
03/17 KYOWA HAKKO KIRIN : KIRIN -Change in the Company Name (trade name) at DAIICHI FI..
03/09 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2 Clinical Study of RTA 402 ..
03/04 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2 Clinical Study of RTA 402 ..
03/04 ArQule Reports Fiscal 2014 Year End and Fourth Quarter Results
02/25 KYOWA HAKKO KIRIN : Patent Issued for Intrabuccally Rapidly Disintegrating Table..
02/18 KYOWA HAKKO KIRIN : Position and policies concerning the reduction of the minimu..
02/17 KYOWA HAKKO KIRIN : Transfer of BioWa's 'External Innovation Engine' In-Licensin..
02/17 KYOWA HAKKO KIRIN : Position and policies concerning the reduction of the minimu..
02/17 KYOWA HAKKO KIRIN : Transfer of BioWa's "External Innovation Engine" In-Licensin..
02/17 KYOWA HAKKO KIRIN : Notice regarding stock acquisition rights for the purpose of..
02/12 KYOWA HAKKO KIRIN : Patent Issued for Intrabuccally Rapidly Disintegrating Table..
01/28 KYOWA HAKKO KIRIN : Findings from Kyowa Hakko Kirin Co. Ltd. in the Area of Dysp..
01/28 KYOWA HAKKO KIRIN : Findings from Kyowa Hakko Kirin Co. Ltd. Provide New Insight..
01/10 KYOWA HAKKO KIRIN : to develop and commercialize Syndax entinostat in Japan and ..
01/08 KYOWA HAKKO KIRIN : to develop and commercialize Syndax's entinostat in Japan an..
2014 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for final dividend
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication for Chemotherapy-Native C..
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication of NESP® for Anemia with ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 KYOWA HAKKO KIRIN : New Influenza A Virus Subtype H1N1 Study Findings Recently W..
2014 Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 Kyowa Hakko Kirin -Launch of Sustained-Duration G-CSF Product G-Lasta in Japa..
2014 KYOWA HAKKO KIRIN : Launch of Sustained-Duration G-CSF Product G-Lasta® in Japan
2014 KYOWA HAKKO KIRIN : Patent Application Titled "Oligonucleotide" Published Online
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 KYOWA HAKKO KIRIN : Announces Completion of Construction for Drug Product Manufa..
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination St..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Approval for Sustained-Duration G-CSF Product G-Lasta in Japan
2014 KYOWA HAKKO KIRIN : Approval for Sustained-Duration G-CSF Product G-Lasta® in Ja..
2014 KYOWA HAKKO KIRIN : Announcement of Results from Long-Term Phase 1/2 Study of KR..
2014 KYOWA HAKKO KIRIN : Launch of Redesigned Kyowa Hakko Kirin Pharma Website
2014 Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
2014 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2b Clinical Study of KHK7580..
2014 KYOWA HAKKO KIRIN : Submits Application for Approval in Japan for KW-3357
2014DJU.S. Stocks Fall Sharply
2014 AstraZeneca buys Almirall lung drugs for up to $2.1 billion
2014 KYOWA HAKKO KIRIN : KIRIN -Announcement of Start of Phase 1 Joint Japanese-Korea..
2014 KYOWA HAKKO KIRIN : Announcement of Start of Phase 1 Joint Japanese-Korean Study..
2014 KYOWA HAKKO KIRIN : Announces Initiation of a Phase 2 Study of KRN23 for Pediatr..
2014 KYOWA KIRIN -Topical Combination Drug Dovobet Ointment Approved to Treat Psor..
2014 KYOWA HAKKO KIRIN : Topical Combination Drug Dovobet® Ointment Approved to Treat..
2014 KYOWA HAKKO KIRIN : Future Development Direction for Bardoxolone Methyl (RTA 402..
2014 KYOWA HAKKO KIRIN : Reapplication Seeking Approval for Additional Indication for..
2014 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
2014 KYOWA HAKKO KIRIN : Announcement of Results from a Multiple Dose Phase 1/2 Study..
2014 KYOWA HAKKO KIRIN : Hisamitsu Pharmaceutical is received Approval for Additional..
2014 KYOWA HAKKO KIRIN : initiates a Phase I Trial of KHK6640 for Alzheimer's Disease..
2014 KYOWA HAKKO KIRIN : Launch of a New Formulation of Topina®, an Antiepileptic Age..
2014 KYOWA HAKKO KIRIN : Termination of Mogamulizumab Licensing Agreement with Amgen
2014 KYOWA HAKKO KIRIN : initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) ..
2014 KYOWA HAKKO KIRIN : Completion of Construction for the biopharmaceutical API man..
2014 KYOWA HAKKO KIRIN : Application Seeking Approval for Additional Indication of NE..
2014 KYOWA HAKKO KIRIN : Matters concerning controlling shareholders(23KB)
2014 KYOWA HAKKO KIRIN : Submits Application for Approval of REGPARA® Tablets 12.5mg ..
2014 KYOWA HAKKO KIRIN : Notice regarding allotment of stock acquisition rights(stock..
1  2Next
Advertisement
Chart
Duration : Period :
Kyowa Hakko Kirin Co Ltd Technical Analysis Chart | 4151 | JP3256000005 | 4-Traders
Income Statement Evolution
More Financials